Adrenergic alpha-Agonists
"Adrenergic alpha-Agonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that selectively bind to and activate alpha adrenergic receptors.
| Descriptor ID |
D000316
|
| MeSH Number(s) |
D27.505.519.625.050.100.100 D27.505.696.577.050.100.100
|
| Concept/Terms |
Adrenergic alpha-Agonists- Adrenergic alpha-Agonists
- Adrenergic alpha Agonists
- alpha-Agonists, Adrenergic
- Receptor Agonists, Adrenergic alpha
- Receptor Agonists, alpha-Adrenergic
- Agonists, alpha-Adrenergic Receptor
- Receptor Agonists, alpha Adrenergic
- alpha-Adrenergic Receptor Agonist
- Agonist, alpha-Adrenergic Receptor
- Receptor Agonist, alpha-Adrenergic
- alpha Adrenergic Receptor Agonist
- alpha-Adrenergic Receptor Agonists
- alpha Adrenergic Receptor Agonists
- Adrenergic alpha-Agonist
- Adrenergic alpha Agonist
- alpha-Agonist, Adrenergic
- alpha-Adrenergic Agonist
- Agonist, alpha-Adrenergic
- alpha Adrenergic Agonist
- alpha-Adrenergic Agonists
- Agonists, alpha-Adrenergic
- alpha Adrenergic Agonists
- Adrenergic alpha-Receptor Agonist
- Adrenergic alpha Receptor Agonist
- Agonist, Adrenergic alpha-Receptor
- alpha-Receptor Agonist, Adrenergic
- Adrenergic alpha-Receptor Agonists
- Adrenergic alpha Receptor Agonists
- Agonists, Adrenergic alpha-Receptor
- alpha-Receptor Agonists, Adrenergic
|
Below are MeSH descriptors whose meaning is more general than "Adrenergic alpha-Agonists".
Below are MeSH descriptors whose meaning is more specific than "Adrenergic alpha-Agonists".
This graph shows the total number of publications written about "Adrenergic alpha-Agonists" by people in this website by year, and whether "Adrenergic alpha-Agonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 1 | 0 | 1 |
| 1994 | 3 | 0 | 3 |
| 1995 | 1 | 2 | 3 |
| 1996 | 2 | 1 | 3 |
| 1997 | 0 | 2 | 2 |
| 1998 | 1 | 0 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 2 | 1 | 3 |
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 2 | 3 |
| 2003 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 1 | 1 | 2 |
| 2006 | 0 | 4 | 4 |
| 2007 | 1 | 1 | 2 |
| 2008 | 2 | 0 | 2 |
| 2013 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adrenergic alpha-Agonists" by people in Profiles.
-
Mittal S, Boan AD, Kral MC, Lally MD, van Bakergem K, Macias MM, LaRosa A. Young Children with Attention-Deficit/Hyperactivity Disorder and/or Disruptive Behavior Disorders Are More Frequently Prescribed Alpha Agonists Than Stimulants. J Child Adolesc Psychopharmacol. 2020 03; 30(2):81-86.
-
Schaffer FM, Naples AR, Ebeling M, Hulsey TC, Garner LM. The safety of self-administered allergen immunotherapy during the buildup and maintenance phases. Int Forum Allergy Rhinol. 2015 Feb; 5(2):149-56.
-
Bryson EO, Briggs MC, Pasculli RM, Kellner CH. Treatment-resistant postictal agitation after electroconvulsive therapy (ECT) controlled with dexmedetomidine. J ECT. 2013 Jun; 29(2):e18.
-
Stamenkovic D, Hassid M. Sedation with dexmedetomidine for vocal fold injection. N Z Med J. 2008 Jun 06; 121(1275):71-3.
-
Dean JM, George S, Naylor AS, Mallard C, Gunn AJ, Bennet L. Partial neuroprotection with low-dose infusion of the alpha2-adrenergic receptor agonist clonidine after severe hypoxia in preterm fetal sheep. Neuropharmacology. 2008 Aug; 55(2):166-74.
-
Carr DB, Andrews GD, Glen WB, Lavin A. alpha2-Noradrenergic receptors activation enhances excitability and synaptic integration in rat prefrontal cortex pyramidal neurons via inhibition of HCN currents. J Physiol. 2007 Oct 15; 584(Pt 2):437-50.
-
Wilson ME, Trivedi RH, Mistr S. Pediatric intraoperative floppy-iris syndrome. J Cataract Refract Surg. 2007 Jul; 33(7):1325-7.
-
Kent AR, King L, Bartholomew LR. Vitreous concentration of topically applied brimonidine-purite 0.15%. J Ocul Pharmacol Ther. 2006 Aug; 22(4):242-6.
-
Gadegbeku CA, Shrayyef MZ, Taylor TP, Egan BM. Mechanism of lipid enhancement of alpha1-adrenoceptor pressor sensitivity in hypertension. J Hypertens. 2006 Jul; 24(7):1383-9.
-
Moeller KE, Barnes BJ, Stanley KM, Worrall CL, Lunsford SL, Simpson KN, Miller JG, Spencer AP. Compliance of an institution-specific alcohol withdrawal protocol with evidence-based practice guidelines. Pharmacotherapy. 2006 Mar; 26(3):445-6.